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Abstract
Radiotherapy is a commonly used conditioning regimen for bone marrow transplantation
(BMT). Cytotoxicity limits the use of this life-saving therapy, but the underlying mechanisms
remain poorly defined. Here, we use the syngeneic mouse BMT model to test the hypothesis
that lethal radiation damages tissues, thereby unleashing signals that indiscriminately acti-
vate the inflammasome pathways in host and transplanted cells. We find that a clinically rel-
evant high dose of radiation causes severe damage to bones and the spleen through
mechanisms involving the NLRP3 and AIM2 inflammasomes but not the NLRC4 inflamma-
some. Downstream, we demonstrate that gasdermin D (GSDMD), the common effector of
the inflammasomes, is also activated by radiation. Remarkably, protection against the injury
induced by deadly ionizing radiation occurs only when NLRP3, AIM2, or GSDMD is lost
simultaneously in both the donor and host cell compartments. Thus, this study reveals a
continuum of the actions of lethal radiation relayed by the inflammasome-GSDMD axis, ini-
tially affecting recipient cells and ultimately harming transplanted cells as they grow in the
severely injured and toxic environment. This study also suggests that therapeutic targeting
of inflammasome-GSDMD signaling has the potential to prevent the collateral effects of
intense radiation regimens.
Introduction
Total body irradiation (TBI) is used in combination with other therapies as a conditioning reg-
imen for the transplantation of bone marrow, cord blood, or hematopoietic stem cells (HSCs)
for patients with hematological malignancies such as acute and chronic leukemia, lymphoma,
and myelodysplastic syndrome [1–3]. TBI followed by HSC transplantation is also
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recommended for the treatment of nonmalignant blood disorders, including hemoglobinopa-
thies, aplastic anemia, and immune deficiencies [3,4]. Thus, TBI-containing conditioning regi-
mens are widely used in the clinic, yet they cause life-threatening injuries and side effects in
multiple organs, including the intestine, lungs, kidney, brain, and spleen [2,4–7].
The skeleton is also adversely affected by radiotherapy, as this procedure damages bone
extracellular matrix, dysregulates the differentiation and activity of bone-forming cells (osteo-
blasts) and hematopoietic bone-resorbing cells (osteoclasts [OCs]), and destroys bone marrow
hematopoiesis niches, events that, ultimately, cause growth retardation, osteoporosis, and
higher fracture risk [8–12]. Thus, the increased survival rates of patients subjected to radio-
therapy raise concerns for long-term skeletal complications, which can worsen other morbidi-
ties. For example, it was reported that 20% to 50% of geriatric patients (�65 years) with a hip
fracture die within 1 year of the injury [13–17]. Therefore, understanding the mechanisms
through which high doses of radiation induce bone toxicity may open avenues for tailored
adjuvant therapies to improve the quality of life of the survivors.
TBI is routinely used in preclinical settings as a myeloablative treatment for allogeneic or
syngeneic adoptive cell transfer (ACT). High doses of TBI cause massive cell death, thereby
generating cues that activate inflammatory pathways, including the inflammasomes, in innate
and adaptive immune cells in the allogeneic or syngeneic models. Consistent with this view,
the inflammasomes, including those assembled by AIM2 and NLRP3, are implicated in radia-
tion-associated tissue injury [18–22]. Thus, although the inflammasomes are a normal partici-
pant in immune responses and tissue repair, their hyperactivation is unhealthy. Yet the extent
to which the activities of the inflammasomes in transplanted and/or host cells impact tissue
outcomes following ACT in animals conditioned by TBI remains poorly understood.
The inflammasomes are intracellular protein complexes that process pro-interleukin-1β
(pro-IL-1β) and pro-IL-18 into IL-1β and IL-18, respectively [23,24]. The inflammasomes also
cleave gasdermin D (GSDMD) into N-terminal GSDMD (GSDMDNt) and C-terminal
GSDMD (GSDMDCt) fragments; the GSDMDNt moieties form pores at the plasma membrane
through which IL-1β and IL-18 are secreted into the extracellular milieu [25–28]. Although
these cytokines are efficiently released by live cells, sustained generation of GSDMDNt causes
cytolysis as the result of excessive pore formation, which compromises the integrity of the
plasma membrane [29–31]. This form of cell demise, called pyroptosis, is proinflammatory as
lysed cells uncontrollably release not only IL-1β and IL-18 but also danger-associated molecu-
lar patterns (DAMPs) such as ATP, high mobility group box 1 (HMGB1), and S100A9 proteins
[32–34]; the release of these DAMPs results in the recruitment of immune cells and the perpet-
uation of inflammation.
In this study, we determined the impact of inflammasome sufficiency or insufficiency in
donor and/or host cells on TBI-induced tissue injury in the syngeneic bone marrow transplan-
tation (BMT) mouse model. We find that this procedure causes systemic inflammation and
damage to several tissues, including bones and the spleen. These anomalies are significantly
reduced when transplanted and recipient cells simultaneously lack NLRP3, AIM2, or GSDMD,
but not NLRC4. These findings establish a novel concept whereby the inflammasome pathways
mediate collateral effects of high dose of radiation not only in resident cells but also in trans-
ferred cells as the result of the toxic environment that this treatment creates in the host.
Results
Radiation causes bone injury
The high prevalence of bone loss following radiotherapy [8–12] provided a strong rationale for
assessing changes in this tissue in mice exposed to a high dose of radiation. To optimize the
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TBI/BMT protocol, we leveraged TRAP-tdTomato (tdT) reporter mice in which the Acp5 pro-
moter drove tdT expression in OC precursors [35], which derived from HSCs [36]. Wild-type
(WT; tdT-) mice were subjected to 9 Gy, a clinically relevant dose of radiation [1,11,12].
Because this radiation was lethal, irradiated animals were inoculated with bone marrow cells
from tdT+ mice to generate tdT+!tdT- mice. Conversely, tdT- cells were injected into irradi-
ated tdT+ mice to obtain tdT-!tdT+ mice. Nonirradiated tdT+ mice and tdT- mice of the same
sex and age served as positive and negative controls, respectively. All nontransplanted, irradi-
ated mice died within 10 days, whereas >95% of transplanted mice overcome the lethality.
Flow cytometry analysis revealed that approximately 6% and 2.5% of bone marrow cells were
tdT+ cells in nonirradiated tdT+ mice and tdT+!tdT- mice, respectively, 3 weeks post TBI/
BMT (S1A and S1B Fig). These values were higher than the 0.6% background fluorescence sig-
nal of tdT- mice and tdT-!tdT+ mice and consistent with the reported frequency of OC pre-
cursors in bone marrow [37–39]. Attempts to confirm the depletion of tdT+ cells by tissue
imaging were unsuccessful, likely because of the modest activity of the Acp5-tdT reporter. In
any case, micro–computed tomography (μCT) analysis revealed that all WT!WT mice devel-
oped time-dependent loss of bone mass (bone volume/total volume [BV/TV]), associated with
increased number and surface of OCs, pronounced adipogenesis, and decreased dynamic indi-
ces of bone formation (S1C–S1H Fig). Thus, lethal radiation efficiently depletes host OC pre-
cursors, which are replaced by donor counterparts. Although radiation adversely affects bone
formation and resorption, this work focuses on the latter phase of bone turnover.
Radiation damages bones through the NLRP3 and AIM2 inflammasomes,
and GSDMD, but not the NLRC4 inflammasome
Endogenous molecules such as ATP and uric acid released by dying cells are sensed as DAMPs
by surrounding live innate cells, leading to the activation of the NLRP3 inflammasome
[22,32,34,40]. The massive cell death that radiation caused to host tissues provided a strong
rationale for investigating its impact on the NLRP3 inflammasome. WT!WT and Nlrp3-/-!
WT male mice exhibited similar bone loss compared to WT controls (Fig 1A and 1B; S2A and
S2B Fig). By contrast, relative to WT mice, bone loss, OC number, and surface were signifi-
cantly attenuated in Nlrp3-/-!Nlrp3-/- mice compared to WT!Nlrp3-/- male mice (Fig 1C–1F;
S2C and S2D Fig). Thus, loss of NLRP3 simultaneously in donor and recipient cells is neces-
sary to significantly reduce radiation-induced bone loss in host mice.
Self-DNA [18–21] and nucleotide-derived metabolites [41] activate the AIM2 and NLRC4
inflammasomes, respectively, though the NLRP3 inflammasome is also activated by mitochon-
drial DNA [42–44]. Given the DNA-destabilizing actions of radiation, we determined the
extent to which the AIM2 and NLRC4 inflammasomes contributed to radiation-mediated
bone injury. Based on the similarity of the phenotype of Nlrp3-/-!WT mice and WT!Nlrp3-/-
mice, Aim2-/- or Nlrc4-/- but not WT mice were used as hosts. Although radiation caused bone
loss and increased OC formation in WT!Aim2-/- mice compared to nonirradiated Aim2-/-
mice, these responses were significantly attenuated in Aim2-/-!Aim2-/- mice (Fig 1G–1J; S2E
and S2F Fig). By contrast, osteolysis occurred in WT!Nlrc4-/- mice comparably to Nlrc4-/-!
Nlrc4-/- mice (Fig 1K–1N; S2G and S2H Fig). Collectively, these results show that TBI causes
bone demise through the NLRP3 and AIM2 inflammasomes but not the NLRC4 inflammasome.
We also assessed the degree to which the massive bone loss that occurred in the TBI/BMT
model was dependent on GSDMD, a downstream target of the inflammasomes and mediator
of pyroptosis [25–28,45]. WT!WT and Gsdmd-/-!WT male mice (Fig 2A and 2B) and
female mice (S3A and S3B Fig) lost bone comparably relative to WT controls. Interestingly,
bone mass was higher whereas OC number and surface were lower in Gsdmd-/-!Gsdmd-/-
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female mice (S3C and S3D Fig) and male mice (Fig 2C–2F; S3E Fig) compared to correspond-
ing WT!Gsdmd-/- mice. Thus, radiation-associated osteolysis is another pathology that impli-
cates GSDMD besides autoinflammatory and autoimmune disorders [45–47].
Given the similarity of the effects of NLRP3, AIM2, or GSDMD deficiency, we focused on
this pore-forming protein to gain mechanistic insights into the actions of radiation. Flow
cytometry analysis revealed that the percentage of the highly osteoclastogenic B220-CD3-
CD11b-/lowCD115+CD117high cells (subset IV) [39,48] was significantly reduced in Gsdmd-/-!
Gsdmd-/- mice compared to WT!Gsdmd-/- mice (Fig 2G; S4 Fig). A similar trend was observed
for B220-CD3-CD11b-/lowCD115+CD117int cells (subset V) and B220-CD3-CD11b-/lowCD115+
CD117low cells (subset VI), which were also endowed with the OC formation potential [39,48]
(Fig 2G). Thus, GSDMD plays a crucial role in the expansion of OC precursors and exuberant
bone resorption caused by radiation.
Radiation-induced tissue injury correlates with the extent of GSDMD
activation
Histological assessments of the spleen of Gsdmd-/- mice showed intact red and white pulp (Fig
2H), similar to WT controls. Remarkably, WT!Gsdmd-/- mice showed effacement of the nor-
mal splenic architecture due to extensive extramedullary hematopoiesis (EMH) that likely was
the cause of the increased spleen weights (Fig 2I). By contrast, Gsdmd-/-!Gsdmd-/- mice dis-
played significant retention of splenic architecture, with less EMH, corresponding to the
smaller spleen size. Consistent with bone outcomes, spleen enlargement was significantly
reduced in Nlrp3-/-!Nlrp3-/- and Aim2-/-!Aim2-/- but not Nlrc4-/-!Nlrc4-/- mice compared
to WT!Nlrp3-/-, WT!Aim2-/-, and WT!Nlrc4-/- mice, respectively (S5A–S5C Fig). Thus,
inactivation of GSDMD in chimeric mice attenuates the severity of spleen injury caused by
high dose of radiation.
We also analyzed the expression and maturation of GSDMD in tissues harvested 2 and 7
days after TBI/BMT. Although the levels of GSDMD were consistently higher in the intestine,
bone marrow, spleen, and liver of WT!WT mice compared to WT mice (Fig 3A and 3B;
S6A and S6B Fig), cleaved GSDMD was detected only in the intestine. Furthermore, GSDMD
was readily detectable in bone marrow and spleen but not in the intestine and liver from
WT!Gsdmd-/- mice 7 days after TBI/BMT (Fig 3A and 3B; S6A and S6B Fig). We observed
similar patterns of GSDMD expression and maturation in tissues from nontransplanted irradi-
ated mice (TBI without BMT), harvested on day 1, 2, or 3 post radiation when BMT was dis-
pensable for the survival of mice (Fig 3C and 3D; S6C and S6D Fig). Noticeably, cleaved
GSDMD was undetectable in the intestine 3 days after irradiation (Fig 3C), likely as the result
of pyroptosis of certain cell populations caused by excessive generation of GSDMDNt frag-
ment. Collectively, these findings ruled out the scenario that the increase in GSDMD levels in
WT!WT tissues relative to WT controls was simply the result of a higher number of cells in
chimeric mice. Thus, radiation induces not only the expression of GSDMD but also its activa-
tion, responses that affect cell fates in tissue in a context-dependent manner.
Fig 1. Radiation damages bones through the NLRP3 and AIM2 inflammasomes but not the NLRC4 inflammasome. Three-month-old WT, Nlrp3-/-,
Aim2-/-, and Nlrc4-/- male mice were left untreated or subjected to 9-Gy TBI. Irradiated mice were transplanted with 107 bone marrow cells from 3-month-old
WT or null male mice to generate WT!WT, Nlrp3-/-!WT, WT!Nlrp3-/-, Nlrp3-/-!Nlrp3-/-, WT!Aim2-/-, Aim2-/-!Aim2-/-, WT!Nlrc4-/-, and
Nlrc4-/-!Nlrc4-/- mice. The femurs were harvested 3 weeks later and analyzed by μCT. (A, C, G, K) Cross sections of 3D reconstructions. (B, D, H, L) BV/TV.
The femurs were also stained for TRAP activity. (E, I, M) TRAP+ cells (OCs), stained in red. (F, J, N) N.Oc/BS. The numerical values underlying Fig 1B, 1D, 1F,
1H, 1J, 1L, 1N can be found in S1 Data. Data are mean ± SEM. �P< 0.05, ��P< 0.005, ���P< 0.0005, ����P< 0.0001. Scale bar: 200 μm. μCT, micro–computed
tomography; BV/TV, bone volume/total volume; N.Oc/BS, OC number/bone surface; ns, not significant; OC, osteoclast; TBI, total body irradiation; WT, wild-
type.
https://doi.org/10.1371/journal.pbio.3000807.g001
PLOS BIOLOGY Radiation dysregulates the inflammasome-GSDMD axis
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000807 August 6, 2020 5 / 19
Fig 2. Radiation damages bones and the spleen through GSDMD. Three-month-old WT and Gsdmd-/- male mice were left untreated or subjected to 9-Gy TBI.
Irradiated mice were transplanted with 107 bone marrow cells from 3-month-old WT or Gsdmd-/- male mice to generate WT!WT, Gsdmd-/-!WT,
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PLOS Biology | https://doi.org/10.1371/journal.pbio.3000807 August 6, 2020 6 / 19
Pro-IL-1β levels in the intestine, bone marrow, spleen, and liver were higher in most
samples from WT!WT or TBI without BMT compared to nonirradiated WT (Figs 3A–3D;
S6A and S6B). Accordingly, the levels of IL-1β measured at the end of the studies (3 weeks
post-TBI/BMT) were higher in the serum from WT!Gsdmd-/- mice compared to
Gsdmd-/-!Gsdmd-/- animals (Fig 3E); a similar trend was noted for serum IL-18 levels (Fig
3F). By contrast, the levels of monocytes, polymorphonuclear cells (PMNs), and lymphocytes
in blood (S6E–S6H Fig) and bone marrow (S6I and S6J Fig) at 3 weeks post TBI/BMT were
not different between WT!Gsdmd-/- mice and Gsdmd-/-!Gsdmd-/- mice. Thus, the absence
of GDSMD in chimeric mice results in decreased radiation-induced secretion of IL-1β and
IL-18, though the number of inflammatory cells in the blood is unaffected at the time of
sampling.
GSDMD exerts OC lineage autonomous actions
The attenuated OC differentiation in Gsdmd-/-!Gsdmd-/- mice may be the result of decreased
secretion of inflammatory cytokines such as IL-1β, which promotes osteoclastogenesis through
various mechanisms, including up-regulation of RANKL expression [36,49]. In addition,
GSDMD may exert actions that are OC lineage autonomous. To test the latter scenario, we
analyzed GSDMD expression during osteoclastogenesis. GSDMD mRNA and protein levels
increased during in vitro OC differentiation of bone marrow–derived macrophages (BMDMs,
Fig 4A–4C) and RAW 264.7 cells (S7A Fig) induced by RANKL. Although cleaved GSDMD
was not detected during osteoclastogenesis, it was processed in OC cultures exposed to nigeri-
cin and lipopolysaccharide (LPS), though to a lesser extent compared to BMDMs (Fig 4C).
Importantly, RANKL-driven OC formation was robust from WT BMDMs but impaired from
Gsdmd-/- cells (Fig 4D and 4E). More importantly, whereas baseline bone mass of non-litter-
mate WT and Gsdmd-/- male mice appeared comparable (Fig 2B and 2D), when littermates
were used, bone mass was higher in Gsdmd-/- mice compared to WT male controls (Fig 4F and
4G), a phenotype that correlated with OC parameters (Fig 4H and 4I). Notably, baseline indi-
ces of bone were comparable between WT and Gsdmd-/- female mice (S3C and S3D Fig).
Thus, whereas GSDMD is dispensable for bone homeostasis in female mice, it is crucial in
physiological bone maintenance in male mice. In light of the OC-promoting actions of irradia-
tion [50], our results suggest that irradiation may induce bone loss through nonautonomous
and autonomous actions in immune cells and the OC cell lineage, respectively.
Discussion
The AIM2 and NLRP3 inflammasomes are rapidly activated in response to perturbing signals,
acting to clear the perceived danger and restore tissue homeostasis [51,52]. The failure of the
organism to rapidly dampen danger signals and fine-tune inflammasome overreactions can be
detrimental to health. These signals can be induced by ionizing radiation, as this procedure
causes genomic instability and cytoplasmic accumulation of DNA, which can be recognized by
AIM2 among other sensors [53]. This procedure also causes cell death, a rich source of the
WT!Gsdmd-/-, and Gsdmd-/-!Gsdmd-/- mice. Samples were harvested 3 weeks later. The femurs were analyzed by μCT. (A, C) Cross sections of 3D
reconstructions. (B, D) BV/TV. The femurs were also stained for TRAP activity. (E) TRAP+ cells (OCs), stained in red. (F) N.Oc/BS. Scale bar: 200 μm. The
percentage of OC progenitors (“prog”) in bone marrow cells was analyzed by flow cytometry (G; the gating is shown in S4 Fig). (H) H&E staining of the spleen.
Scale bar: 100 μm. (I) Percentage of spleen weights. The numerical values underlying Fig 2B, 2D, 2F, 2G, 2I can be found in S1 Data. Data are mean ± SEM.
�P< 0.05, ��P< 0.005, ���P< 0.0005, ����P< 0.0001. μCT, micro–computed tomography; BV/TV, bone volume/total volume; GSDMD, gasdermin D; H&E,
hematoxylin and eosin; N.Oc/BS, OC number/bone surface; ns, not significant; OC, osteoclast; TBI, total body irradiation; WT, wild-type.
https://doi.org/10.1371/journal.pbio.3000807.g002
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Fig 3. Radiation-induced systemic inflammation correlates with the extent of GSDMD activation. (A, B, E, F) Three-month-old WT or Gsdmd-/- male mice were
left untreated or subjected to 9-Gy TBI. Irradiated mice were transplanted with 107 bone marrow cells from 3-month-old WT or Gsdmd-/- male mice to generate
PLOS BIOLOGY Radiation dysregulates the inflammasome-GSDMD axis
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activators of the NLRP3 inflammasome such as ATP and uric acid [22,32,54,55]. Our results
reinforce the view that radiation-inflammasome cascades are harmful, since the multiorgan
damage induced by a high dose of radiation is profoundly attenuated when mice lack the
inflammasome sensing components (NLRP3 or AIM2) in donor and recipient cells. Although
a recent study suggests that focal irradiation promotes intestinal injury via the AIM2 inflam-
masome [18], here we show that TBI causes systemic tissue demise through the NLRP3 and
AIM2 inflammasomes but not the NLRC4 inflammasome, actions that culminate in the activa-
tion of GSDMD. The residual tissue damage seen in some Gsdmd-deficient mice may be
driven by GSDME, which is also expressed by hematopoietic cells, including macrophages,
and mediates pyroptosis [56–60]. Another eloquent study shows that acute graft-versus-host
disease (GvHD) is unaffected in Nlrp3-/-!WT mice, consistent with our results; however, this
work conflicts with ours, as it finds that GvHD is significantly delayed in WT!Nlrp3-/- mice
[22]. Differences in the experimental designs and endpoint outcomes may account for the
apparent discrepant observations. Our findings position GSDMD downstream of the NLRP3
and AIM2 inflammasomes in response to radiation-triggered signaling cascades. However,
further studies are needed to determine whether or not NLRP3 and AIM2 are recruited to the
same inflammasome complexes in irradiated cells as reported in murine cells exposed to
cGAMP [61]. Since AIM2 senses DNA, it will also be interesting to determine the impact of
deficiency in DNA repair on radiation-induced inflammasome activation. Poly(ADP-ribose)
polymerases (PARPs), which are involved in DNA repair and affected by inflammasome sig-
naling, are attractive candidates for such studies [62–66].
Serum levels of IL-1β correlate with the extent of bone loss in chimeric mice, findings that
are consistent with the ability of this cytokine to regulate the expression of osteoclastogenic
factors such as RANKL and to expand myeloid cell populations, some of which are OC precur-
sors [36,67]. Serum levels of IL-1β in these mice also correlate with the magnitude of spleen
enlargement, an outcome that is likely caused by the extensive EMH that occurs in this tissue
as a homeostatic compensatory response to compromised hematopoiesis in the bone marrow.
Consistent with skeletal outcomes, the increase in cytokine secretion and spleen weights are
significantly reduced in chimeric mice fully lacking GSDMD. However, blood cell counts are
unaffected in these mice compared to WT!Gsdmd-/- mice, perhaps as the result of systemic
inflammation in the latter mouse strain returning to baseline levels at the time of the sampling.
The increased levels of GSDMD during OC differentiation are unanticipated considering
its pyroptotic actions. GSDMD is also unexpectedly not cleaved during osteoclastogenesis, yet
its loss results in decreased OC differentiation both in vitro and in vivo. These results, in con-
junction with those showing that LPS and nigericin induce the cleavage of this protein in OC
cultures, rule out the scenario of defective inflammasome signaling in the OC lineage. How-
ever, the expression of GSDMD and maturation by terminally differentiated OCs still needs to
be proven, given the cellular heterogeneity of OC cultures. Despite this knowledge gap, our
findings revealing that GSDMD plays an important role in the differentiation of myeloid cells
are novel because previous studies have focused on the function and regulation of this protein
in inflammatory cells [25–27,68].
In summary, this study was driven by the hypothesis that the high sensitivity of the inflam-
masome pathways to homeostatic perturbations should, in theory, predispose these
WT!WT, Gsdmd-/-!Gsdmd-/-, and WT!Gsdmd-/ mice. (C, D) Three-month-old WT male mice were left untreated or subjected to 9-Gy TBI (irradiated mice were
not transplanted with bone marrow cells). Samples from 1–2 mice/group were collected 2 or 7 days after TBI/BMT (A, B) or 1, 2, and 3 days post TBI (C, D) and
analyzed alongside control (”Cont”) lysates by immunoblotting. (E, F) IL-1β and IL-18 levels in the serum from chimeric mice (3 weeks post TBI/BMT) and control
mice. The data underlying this figure may be found in S1 Data and S2 Data. Data are mean ± SEM. �P< 0.05. BMT, bone marrow transplantation; GSDMD, gasdermin
D; IL, interleukin; ns, not significant; TBI, total body irradiation; WT, wild-type.
https://doi.org/10.1371/journal.pbio.3000807.g003
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Fig 4. GSDMD exerts OC lineage autonomous actions. (A, B) BMDMs were treated with M-CSF and RANKL expressed in Escherichia coli (in-house RANKL) or
commercial RANKL (to rule out potential effects caused by LPS contamination) for the indicated days. GSDMD expression was analyzed by qPCR (A) or
PLOS BIOLOGY Radiation dysregulates the inflammasome-GSDMD axis
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multifunctional protein platforms to aberrant activation by excessive ionizing radiation sig-
nals. Additionally, the inflammasomes should be activated not only in the irradiated host cells
but also in the donor cells as they engraft in the damaged tissues. We have validated this new
concept by demonstrating that suppression of inflammasome-GSDMD signaling in both




All procedures were approved by the Institutional Animal Care and Use Committee (IACUC)
of Washington University School of Medicine in St. Louis. All experiments were performed in
accordance with the relevant guidelines and regulations described in the IACUC-approved
protocol 19-0971.
Mice
Gsdmd knockout (Gsdmd−/−) mice and Nlrc4−/− mice were kindly provided by Dr. V. M. Dixit
(Genentech, South San Francisco, CA, United States of America). Aim2−/− mice were pur-
chased from Jackson Laboratory (Sacramento, CA, USA). Nlrp3−/− mice have been described
previously [69]. All mice were on the C57BL6 background, and mouse genotyping was per-
formed by PCR.
BMT
Recipient mice were subjected to 9 Gy of TBI using X-RAD 320 Biological Irradiator (Preci-
sion X-Ray, North Branford, CT, USA). Bone marrow cells were flushed out from the femurs
and tibias with phosphate buffered saline (PBS), filtered using 70-μm nylon mesh. Red blood
cells were lysed, and 107 bone marrow cells in 100 μl PBS were intravenously injected through
the tail vein. Mice were supplied with water containing antibiotics (sulfamethoxazole and tri-
methoprim oral suspension [Ca# NDC 50383-824-16, AKORN, Lake Forest, IL, USA]).
Flow cytometry
Bone marrow cells were flushed out from the femurs and tibias with PBS. Single cell suspen-
sions at 1× 106/200 μl were incubated with antibodies for 30 minutes at 4˚C. The antibodies
included CD3 PE-CY7 (Cat# 552774) and CD11b BB515 (Cat# 564454) from BD Biosciences
(San Jose, CA, USA), B220 PerCP (Cat# 45-0452-82), CD115 PE (Cat# 12-1152-83), Gr-1 APC
(Cat# 17-5931-82), and cKit e780 (Cat# 47-1172-82) from Thermo Fisher Scientific (Waltham,
MA, USA). Flow cytometry analysis was performed using LSR Fortessa or FACS Canto II.
Data were analyzed using FlowJo software (Tree Star).
immunoblotting (B). (C) BMDMs and OCs from BMDMs treated with M-CSF and RANKL for 4 days were exposed to 100 ng/ml LPS for 3 hours, then vehicle or
15 μM nigericin for 30 minutes. Cell lysates were analyzed by immunoblotting. (D, E) BMDMs from WT and Gsdmd-/- mice were treated with M-CSF and RANKL for
4 days. Cultures were stained for TRAP activity. (D) Pictures of TRAP+ cells. (E) Counts of TRAP+ multinucleated cells (OCs, indicated by arrowheads). The femurs
from 3-month-old WT and Gsdmd-/- male mice were analyzed by μCT. (F) Cross sections of 3D reconstructions. (G) BV/TV. The femurs were also stained for TRAP
activity. (H) TRAP+ cells (OCs), stained in red. (I) N.Oc/BS. Scale bar: 200 μm. The data underlying this figure may be found in S1 Data and S2 Data. Data are
mean ± SEM. �P< 0.05; ��P< 0.005; ���P< 0.0005. μCT, micro–computed tomography; BMDMs, bone marrow–derived macrophages; BV/TV, bone volume/total
volume; GSDMD, gasdermin D; LPS, lipopolysaccharide; N.Oc/BS, OC number/bone surface; OC, osteoclast; qPCR, quantitative PCR; WT, wild-type.
https://doi.org/10.1371/journal.pbio.3000807.g004
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Bone microstructure and histomorphometry
The femurs were embedded in 2% agarose gel and scanned at 10 μm, 55 kVp, 145 μA, 8 W,
300-ms integration time using a μCT system (μCT 40; Scanco Medical AG, Zurich, Switzer-
land) as previously described [70,71]. The regions of interest (ROIs) were defined at 1 mm
proximal to the end of the femoral growth plate.
For static histomorphometry, the femurs were fixed in 10% neutral buffered formalin for
16–24 hours, decalcified in 14% (w/v) EDTA (pH 7.2) for 10–14 days at room temperature,
stored in 70% ethanol, paraffin-embedded, and sections at 5 μm. They were stained for tar-
trate-resistant acid phosphatase as previously described [72]. Images were acquired using a
NanoZoomer 2.0 HT whole slide scanner (Hamamatsu Photonics, Hamamatsu City, Shizuoka,
Japan) at 20× magnification. Bioquant Osteo software (v18.2.6; Bioquant Image Analysis
Corp., Nashville, TN, USA) was used for image analysis. Static indices were measured in a 2-
mm ROI defined 100 μm from the end of the primary spongiosa.
For dynamic histomorphometry, mice were intraperitoneally injected with 10 mg/kg cal-
cein green (Sigma-Aldrich, Cat# C0875, St. Louis, MO, USA) and 4 days later with 50 mg/kg
alizarin red (Sigma-Aldrich, Cat# A3882). Mice were euthanized 2 days after the second injec-
tion. The left tibias and femurs were collected and fixed in 70% ethanol overnight, embedded
in methyl methacrylate, and sectioned at 7–10 μm. Images were obtained using NanoZoomer.
Measurements of dynamic bone histomorphometry were calculated from fluorochrome dou-
ble labels at the endocortical surfaces as previously described [72].
For spleen histology, tissues were fixed in 10% formalin overnight, then embedded in paraf-
fin followed by sectioning at 5 μm. After being mounted to positively charged glass slides, sec-
tions were dried and performed with hematoxylin-eosin (H&E) staining by standard methods.
OC differentiation and TRAP staining
Mice were euthanized and bone marrow was flushed out from the tibias and femurs. BMDMs
were obtained by culturing bone marrow cells in media containing 10% CMG, a source of
M-CSF, for up to 5 days in a 10-cm dish as previously described [70,73]. After removing the
nonadherent cells by vigorous washes with PBS, adherent cells were plated at 5 to 10 × 103/well
in a 96-well plate in culture media containing 2% CMG and 50–100 ng/ml RANKL. Cells were
maintained at 37˚C in a humidified atmosphere of 5% CO2, with media changed every other
day. At the end of the culture period, the cells were rinsed with water and incubated with the
TRAP staining solution (Sigma leukocyte acid phosphatase kit) at room temperature for 30
minutes. Multinucleated TRAP-positive cells with at least 3 nuclei were scored as OC under
light microscopy.
RNA isolation and RT-qPCR
RNA was extracted from cells by using RNeasy Plus Mini Kit (Qiagen). cDNA was prepared
using High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems). Gene expression
was detected by qPCR using SYBR Green (Applied Biosystems) according to the manufacture.
The data were analyzed using the ΔΔCT method normalizing against cyclophilin B.
Western blot
BMDMs and OCs were primed with 100 ng/mL LPS for 3 hours, then treated with 15 μM
nigericin for 30 minutes. To collect proteins, cells or tissues were lysed with RIPA buffer (50
mM Tris, 150 mM NaCl, 1 mM EDTA, 0.5% NaDOAc, 0.1% SDS, and 1.0% NP-40) plus Com-
plete Protease Inhibitor Cocktail and phosphatase inhibitors (Roche, South San Francisco, CA,
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USA). Protein concentrations from cell lysates and tissue lysates were determined by Bio-Rad
method. Proteins were separated by SDS-PAGE (12%) and transferred to PVDF membrane.
Proteins were stained with antibodies against GSDMD (1:1,000, ab209845, Abcam), or β-actin
(1:5,000, sc-47778, Santa Cruz Biotechnology, Dallas, TX, USA) overnight at 4˚C, followed by
a 1-hour incubation with secondary goat anti-rabbit IgG (1:5,000, A21109, Thermo Fisher Sci-
entific, Waltham, MA, USA) or goat anti-mouse IgG (1:5,000, A21058, Thermo Fisher Scien-
tific, Waltham, MA, USA), respectively. The signals were developed using Li-Cor Odyssey
Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).
Measurements of IL-1β and IL-18 levels
For IL-1β measurements in bone marrow, flushed bone marrow was centrifuged, and the
supernatants were collected as described previously. IL-1β levels were measured and quantified
using Luminex kits (Minneapolis, MN, USA).
Statistical analysis
Statistical analysis was performed using Student t test, one-way ANOVA with Tukey’s multi-
ple-comparisons test, or two-way ANOVA with Tukey’s multiple-comparisons test in Graph-
Pad Prism7.
Supporting information
S1 Fig. Radiation causes bone injury. (A, B) Three-month-old WT (tdT-) male mice were
subjected to 9-Gy TBI, then inoculated with bone marrow cells from tdT+ male mice to gener-
ate tdT+!tdT- mice. Conversely, tdT- cells were injected into irradiated tdT+ mice to obtain
tdT-!tdT+ mice. Nonirradiated tdT+ mice and tdT- male mice of the same age were used as
positive and negative controls, respectively. Bone marrow cells were harvested 3 weeks later
and analyzed by flow cytometry. (C-H) Three-month-old WT male mice left untreated or irra-
diated and transplanted with 107 bone marrow cells (WT!WT mice) were labeled with cal-
cein green and alizarin red. The femurs were analyzed by μCT analysis. (C) Cross sections of
3D reconstructions. (D) BV/TV. The femurs were also stained for TRAP activity. (E) TRAP+
cells (OCs), stained in red. (F) N.Oc/BS. The tibias were also analyzed by histology. (G) Pic-
tures of double-labeled bone surfaces. (H) MAR. The numerical values underlying S1B,
D, F, H Fig can be found in S1 Data. Data are mean ± SEM. ��P< 0.005; ���P< 0.0005,
����P< 0.0001. μCT, micro–computed tomography; BV/TV, bone volume/total volume;
MAR, mineral apposition rate; N.Oc/BS, OC number/bone surface; OC, osteoclast; TBI, total
body irradiation; tdT, tdTomato; WT, wild-type.
(TIF)
S2 Fig. Radiation damages bones through the NLRP3 and AIM2 inflammasomes but not
the NLRC4 inflammasome. Three-month-old WT and Nlrp3-/- male mice were left untreated
or subjected to 9-Gy TBI. Irradiated mice were transplanted with 107 bone marrow cells from
3-month-old WT or Nlrp3-/- male mice to generate Nlrp3-/-!WT, WT!WT, WT!Nlrp3-/-,
Nlrp3-/-!Nlrp3-/-, WT!Aim2-/-, Aim2-/-!Aim2-/-, WT!Nlrc4-/-, and Nlrc4-/-!Nlrc4-/- mice.
The femurs were analyzed by μCT. (A, C, E, G) vBMD. The femurs were also stained for
TRAP activity. (B, D, F, H) Oc.S/BS. Scale bar: 200 μm. The numerical values underlying
S2A–S2H Fig can be found in S1 Data. Data are mean ± SEM. �P< 0.05, ��P< 0.005,
���P< 0.0005. μCT, micro–computed tomography; ns, not significant; Oc.S/BS, OC surface/
bone surface; TBI, total body irradiation; vBMD, volumetric bone mineral density; WT, wild-
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type
(TIF)
S3 Fig. Radiation damages bones through GSDMD. Three-month-old WT and Gsdmd-/-
female mice (A-D) and male mice (E) were left untreated or subjected to 9-Gy TBI. Irradiated
mice were transplanted with 107 bone marrow cells from 3-month-old WT or null mice of the
corresponding sex to generate WT!WT, Gsdmd-/-!WT, WT!Gsdmd-/- and
Gsdmd-/-!Gsdmd-/- mice. The femurs were analyzed by μCT. (A, C) Cross sections of 3D
reconstructions. (B, D) BV/TV. The femurs were also stained for TRAP activity. (E) Oc.S/BS.
The numerical values underlying S3B, D, E Fig can be found in S1 Data. Data are
mean ± SEM. ���P< 0.0005; ����P< 0.0001. Scale bar: 200 μm. μCT, micro–computed
tomography; BV/TV, bone volume/total volume; GSDMD, gasdermin D; ns, not significant;
Oc.S/BS, OC surface/bone surface; TBI, total body irradiation; WT, wild-type.
(TIF)
S4 Fig. Gating strategy for the flow cytometry data shown in Fig 2G.
(TIF)
S5 Fig. Radiation damages the spleen through the NLRP3 and AIM2 inflammasomes but
not the NLRC4 inflammasome. Three-month-old Nlrp3-/-, Aim2-/-, or Nlrc4-/- male mice
were left untreated or subjected to 9-Gy TBI. Irradiated mice were transplanted with 107 bone
marrow cells from 3-month-old male mice to generate WT!Nlrp3-/- and Nlrp3-/-!Nlrp3-/-
mice (A), WT!Aim2-/- and Aim2-/-!Aim2-/- mice (B), and WT!Nlrc4-/- and
Nlrc4-/-!Nlrc4-/- mice (C). The spleen was analyzed 3 weeks later; the weight was normalized
to the body weight. The numerical values underlying S5A–C Fig can be found in S1 Data. Data
are mean ± SEM. �P< 0.05; ��P< 0.005; ���P< 0.0005; ����P< 0.0001. ns, not significant;
TBI, total body irradiation; WT, wild-type.
(TIF)
S6 Fig. Radiation-induced tissue injury correlates with the extent of GSDMD activation.
(A, B, E-J) Three-month-old WT mice or Gsdmd-/- male mice were left untreated or subjected
to 9-Gy TBI. Irradiated mice were transplanted with 107 bone marrow cells from 3-month-old
WT or Gsdmd-/- male mice to generate WT!WT, Gsdmd-/-!Gsdmd-/-, and WT!Gsdmd-/-
mice. (C, D) Three-month-old WT male mice were left untreated or subjected to 9-Gy TBI;
irradiated mice were not transplanted with bone marrow cells. Samples were collected 2 or 7
days post TBI/BMT (A, B); 3 weeks post-TBI/BMT (E-J); and 1, 2, or 3 days after TBI (C, D);
and analyzed alongside control lysates by immunoblotting (1–2 mice/group) or flow cytome-
try. The data underlying this figure may be found in S1 Data and S2 Data. Data are
mean ± SEM. ��P< 0.005; ����P< 0.0001. BMT, bone marrow transplantation; GSDMD, gas-
dermin D; ns, not significant; TBI, total body irradiation; WT, wild-type.
(TIF)
S7 Fig. GSDMD expression increases during OC differentiation. (A) RAW 264.7 cells were
treated with RANKL for the indicated days. GSDMD expression was analyzed by qPCR. The
numerical values underlying S7A Fig can be found in S1 Data. (B) Data are from http://biogps.
org/#goto=genereport&id=69146. GSDMD, gasdermin D; OC, osteoclast; qPCR, quantitative
PCR.
(TIF)
S1 Data. This spreadsheet contains raw data used to plot the graphs Fig 1B, 1D, 1F, 11H,
1J, 1L and 1N; Fig 2B, 2D, 2F, 2G and 2I; Fig 3E and 3F; Fig 4A, 4E, 4G and 4I; S1B, S1D,
S1F and S1H Fig; S2A–S2H Fig; S3B, S3D, and S3E Fig; S5A–S5C Fig; S6E–S6J Fig; and
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S7A Fig.
(XLSX)
S2 Data. This file contains the original images supporting the blots for Fig 3A–3D, Fig 4B
and 4C, S6A–S6D Fig.
(PPTX)
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